Epidemiological data on the use of traditional anticoagulants in cardiovascular disease

Epidemiological data on the use of traditional anticoagulants in cardiovascular disease

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Reith, C, Baigent, C
مؤلفون آخرون:	DeCaterina, R
التنسيق:	Book section
منشور في:	Oxford University Press 2018

مواد مشابهة

Role of aspirin in primary prevention of cardiovascular disease
حسب: Patrono, C, وآخرون
منشور في: (2019)

Clinical effects of anticoagulants in suspected acute myocardial infarction - Reply
حسب: Collins, R, وآخرون
منشور في: (1997)

Coxibs, traditional NSAIDs and cardiovascular safety post-PRECISION: What we thought we knew then and what we think we know now
حسب: Patrono, C, وآخرون
منشور في: (2017)

Renal function: an emerging risk factor for cardiovascular disease?
حسب: Landray, M, وآخرون
منشور في: (2001)

A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease
حسب: Schlackow, I, وآخرون
منشور في: (2017)

Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.
حسب: Baigent, C, وآخرون
منشور في: (2003)

Anticoagulants in heart disease: current status and perspectives.
حسب: De Caterina, R, وآخرون
منشور في: (2007)

Which cardiovascular risk factors matter in chronic kidney disease?
حسب: Baigent, C, وآخرون
منشور في: (2007)

Premature cardiovascular disease in chronic renal failure.
حسب: Baigent, C, وآخرون
منشور في: (2000)

Use of Bivalirudin for Anticoagulation in Interventional Cardiovascular Procedures
حسب: Zhen Ge, وآخرون
منشور في: (2018-06-01)

Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesis.
حسب: Hennekens, C, وآخرون
منشور في: (2006)

The Epidemiology of Cardiovascular Disease
حسب: Hobbs, R, وآخرون
منشور في: (2009)

Cardiovascular disease: PCSK9 inhibition: a new player in cholesterol-lowering therapies?
حسب: Preiss, D, وآخرون
منشور في: (2017)

Benefits of lowering cholesterol in chronic kidney disease Reply
حسب: Baigent, C, وآخرون
منشور في: (2011)

Angiotensin receptor blockers and β-blockers in Marfan syndrome: an individual-patient-data meta-analysis of randomised trials
حسب: Pitcher, A, وآخرون
منشور في: (2022)

Should we reduce blood cholesterol to prevent cardiovascular disease among patients with chronic renal failure?
حسب: Baigent, C, وآخرون
منشور في: (2000)

Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment.
حسب: Landray, M, وآخرون
منشور في: (2001)

Epidemiology of cardiovascular disease in Europe
حسب: Wright, F
منشور في: (2021)

Anticoagulation regimes and their influence on the occlusion rate of aneurysms: an experimental study in rabbits.
حسب: Grunwald, I, وآخرون
منشور في: (2005)

Traditional and Non-traditional Cardiovascular Risk Factors and Cardiovascular Disease in Women with Psoriasis
حسب: Charlotte Näslund-Koch, وآخرون
منشور في: (2022-10-01)

Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease.
حسب: De Caterina, R, وآخرون
منشور في: (2013)

Deaths from cardiovascular disease involving anticoagulants: a systematic synthesis of coroners' case reports
حسب: Anis, A, وآخرون
منشور في: (2022)

Deaths from cardiovascular disease involving anticoagulants: a systematic synthesis of coroners’ case reports
حسب: Ali Anis, وآخرون
منشور في: (2022-03-01)

The urgent need for a policy on epidemiological data on cardiovascular diseases in Bangladesh
حسب: Amrin Yeasin Proma, وآخرون
منشور في: (2023-07-01)

Editorial: Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey areas
حسب: Antonino Tuttolomondo, وآخرون
منشور في: (2023-10-01)

Traditional Chinese Medicine Is Widely Used for Cardiovascular Disease
حسب: Dan Hu, وآخرون
منشور في: (2018-04-01)

General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.
حسب: De Caterina, R, وآخرون
منشور في: (2013)

Statins for people at low risk of cardiovascular disease reply
حسب: Mihaylova, B, وآخرون
منشور في: (2012)

Cardiovascular disease in Europe: epidemiological update.
حسب: Nichols, M, وآخرون
منشور في: (2013)

Epidemiological Features of Cardiovascular Disease in Asia
حسب: Dong Zhao, MD, PhD
منشور في: (2021-06-01)

New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper.
حسب: De Caterina, R, وآخرون
منشور في: (2012)

Evidence for reverse causality in the association between blood pressure and cardiovascular risk in patients with chronic kidney disease
حسب: Herrington, W, وآخرون
منشور في: (2016)

SURGICAL TREATMENT OF HEMORRHOIDAL BLEEDING IN PATIENTS WITH CARDIOVASCULAR DISEASES UNDER ANTICOAGULANT AND ANTIPLATELET THERAPY
حسب: A. Z. Tsitskarava, وآخرون
منشور في: (2019-12-01)

Direct Oral Anticoagulants Versus Traditional Anticoagulation in Cirrhotic Patients with Portal Vein Thrombosis: Updated Systematic Review
حسب: Xiulin Xiao M.S., وآخرون
منشور في: (2024-11-01)

Cancer and cardiovascular disease after vasectomy: an epidemiological database study.
حسب: Goldacre, M, وآخرون
منشور في: (2005)

Atrial Fibrillation and Risk of Dementia: Epidemiology, Mechanisms, and Effect of Anticoagulation
حسب: Rose Mary Ferreira Lisboa Da Silva, وآخرون
منشور في: (2019-01-01)

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
حسب: Storey, B, وآخرون
منشور في: (2017)

Coxibs and traditional NSAIDs for pain relief - Authors' reply.
حسب: Bhala, N, وآخرون
منشور في: (2014)

Trends in the epidemiology of cardiovascular disease in the United Kingdom
حسب: Bhatnagar, P, وآخرون
منشور في: (2016)

Cardiovascular disease in Europe 2014: epidemiological update.
حسب: Nichols, M, وآخرون
منشور في: (2014)